• 제목/요약/키워드: Low risk criteria

검색결과 247건 처리시간 0.027초

불면장애에 대한 천왕보심단의 체계적 문헌 고찰 및 메타분석 연구 (Herbal Medicine (Cheonwangbosim-Dan, Tianwangbuxin-Pellet) for Insomnia Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials)

  • 사공종원;김동희;하지원;조윤송;김보경
    • 동의신경정신과학회지
    • /
    • 제29권4호
    • /
    • pp.267-280
    • /
    • 2018
  • Objectives: The objective of this study was to provide clinical evidence to support the use of a herbal medicine (Cheonwangbosim-Dan/Tianwangbuxin-Pellet (TWBXP)) for insomnia. Methods: Randomized controlled trials that verified effects of Herbal Medicine (Cheonwangbosim-Dan, Tianwangbuxin-Pellet) treating primary insomnia were carried out. A literature search of English, Chinese, Korean databases was also performed. The selected literature were assessed by Risk of Bias (RoB). Results: The total number of selected trials was 13 RCTs. Among the 13 RCTs, 10 were meta-analyzed. The Chinese Classification of Mental Disorders-3 (CCMD-3) was frequently used as the diagnostic criteria for interventions during the analysis of the use of herbal medicine (Cheonwangbosim-Dan/Tianwangbuxin-Pellet) for management of primary insomnia. As for outcome measurement, the effective rate was used. From the Meta-analysis of the studies, it was established that the insomnia cure effective rate in the TWBXP group was higher than that in the Western Medicine (WM) group (RR: 1.15, 95% CI: 1.07 to 1.24, p<0.0001, $I^2=33%$). Also, the effective rate in the TWBXP+ACU group was significantly different compared to the WM group (RR: 1.32, 95% CI: 1.13 to 1.54, p=0.0004, $I^2=0%$). The quality of the selected RCTs was low. Conclusions: Herbal medicine (Cheonwangbosim-Dan/Tianwangbuxin-Pellet) is effective for treating primary insomnia. It is worth noting that this studies were of relatively poor quality. The sample sizes were also small. Therefore, further investigations into the diagnosis and treatment of insomnia are warranted.

국내 유통 식품용 유리제의 중금속 노출 평가 (Exposure Assessment of Heavy Metals Migrated from Glassware on the Korean Market)

  • 김은비;황정분;이정은;최재천;박세종;이종권
    • 한국포장학회지
    • /
    • 제28권1호
    • /
    • pp.15-21
    • /
    • 2022
  • 본 연구는 국내 유통 되는 식품용 유리제 총 110개 제품을 대상으로 유리제에서 식품으로 이행될 우려가 있는 납, 카드뮴 및 바륨에 대하여 이행량을 조사하고 안전성 평가를 실시하였다. 납, 카드뮴 및 바륨은 ICP-OES로 측정되었고, 시험법은 직선성, 검출한계, 정량한계, 회수율, 정밀도 및 측정불확도 추정에 의해 검증되었다. 납과 바륨의 이행량은 각각 불검출 ~ 0.7949 mg/L 및 불검출 ~ 0.1823 mg/L 이었으며, 카드뮴은 모든 시료에서 검출되지 않았다. 식이를 통한 이행물질의 일일추정섭취량 및 위해도를 확인한 결과 국내 유통되는 식품용 유리제는 안전하게 관리되고 있음을 확인하였다.

Morbidity and Mortality Trends in Preterm Infants of <32 Weeks Gestational Age with Severe Intraventricular Hemorrhage : A 14-Year Single-Center Retrospective Study

  • Eui Kyung Choi;Hyo-jeong Kim;Bo-Kyung Je;Byung Min Choi;Sang-Dae Kim
    • Journal of Korean Neurosurgical Society
    • /
    • 제66권3호
    • /
    • pp.316-323
    • /
    • 2023
  • Objective : Owing to advances in critical care treatment, the overall survival rate of preterm infants born at a gestational age (GA) <32 weeks has consistently improved. However, the incidence of severe intraventricular hemorrhage (IVH) has persisted, and there are few reports on in-hospital morbidity and mortality. Therefore, the aim of the present study was to investigate trends surrounding in-hospital morbidity and mortality of preterm infants with severe IVH over a 14-year period. Methods : This single-center retrospective study included 620 infants born at a GA <32 weeks, admitted between January 2007 and December 2020. After applying exclusion criteria, 596 patients were included in this study. Infants were grouped based on the most severe IVH grade documented on brain ultrasonography during their admission, with grades 3 and 4 defined as severe. We compared in-hospital mortality and clinical outcomes of preterm infants with severe IVH for two time periods : 2007-2013 (phase I) and 2014-2020 (phase II). Baseline characteristics of infants who died and survived during hospitalization were analyzed. Results : A total of 54 infants (9.0%) were diagnosed with severe IVH over a 14-year period; overall in-hospital mortality rate was 29.6%. Late in-hospital mortality rate (>7 days after birth) for infants with severe IVH significantly improved over time, decreasing from 39.1% in phase I to 14.3% in phase II (p=0.043). A history of hypotension treated with vasoactive medication within 1 week after birth (adjusted odds ratio, 7.39; p=0.025) was found to be an independent risk factor for mortality. When comparing major morbidities of surviving infants, those in phase II were significantly more likely to have undergone surgery for necrotizing enterocolitis (NEC) (29.2% vs. 0.0%; p=0.027). Additionally, rates of late-onset sepsis (45.8% vs. 14.3%; p=0.049) and central nervous system infection (25.0% vs. 0.0%; p=0.049) were significantly higher in phase II survivors than in phase I survivors. Conclusion : In-hospital mortality in preterm infants with severe IVH decreased over the last decade, whereas major neonatal morbidities increased, particularly surgical NEC and sepsis. This study suggests the importance of multidisciplinary specialized medical and surgical neonatal intensive care in preterm infants with severe IVH.

월경전증후군에 대한 한약 치료의 효과 : 체계적 문헌 고찰과 메타 분석 (Herbal Medicine for Premenstrual Syndrome: A Systematic Review and Meta-analysis)

  • 서지인;이윤재;고서림;김누리;김정훈;손미주;김영은;김안나;이은희
    • 대한한방부인과학회지
    • /
    • 제36권4호
    • /
    • pp.96-120
    • /
    • 2023
  • Objectives: This study reports the findings that support the efficacy of herbal medicine (HM) for premenstrual syndrome (PMS). Methods: We conducted meta-analysis of findings from randomized controlled trials (RCTs) for PMS treated with HM. The articles were published before July 2022, located using 9 databases (Pubmed, EMBASE, Cochrane Library, CINAHL, CNKI, CiNii, SCIENCE ON, KoreaMed, OASIS). Results: We observed 2,034 studies, of which 23 RCTs met our inclusion criteria. The risk of bias in the included studies was relatively unclear or high. Meta-analysis of 3 RCTs showed that HM group had a significantly higher total effective rate than the western medicine group (RR 1.20 [95% CI 1.06, 1.36, p=0.004]). Meta-analysis of 1 RCT showed that HM group had a significantly lower symptom score (MD -3.04 [95% CI -5.36, -0.72, p=0.01]), while there was no significant difference in daily record of severity of problems scale (MD -20.52 [95% CI -49.33, 8.29, p=0.16]). Conclusions: HM significantly improved PMS symptoms than general treatment and no serious adverse events were reported. However, the evidence on the effectiveness and safety of HM for PMS was not enough to provide reliable results due to the small number and low quality of included studies. We believe that rigorous RCTs will lead to more reliable evidence of the intervention.

갑상선 미세유두암의 고주파 절제술 후 10년 경과 관찰 (Radiofrequency Ablation of Papillary Thyroid Microcarcinoma: A 10-Year Follow-Up Study)

  • 서유경;조성휘;심정석;양고은;조우진
    • 대한영상의학회지
    • /
    • 제82권4호
    • /
    • pp.914-922
    • /
    • 2021
  • 목적 이 연구는 갑상선 미세유두암을 고주파 절제술로 치료한 후 10년 이상 경과 관찰한 환자들의 결과를 통해 효과와 안전성을 평가하고자 했다. 대상과 방법 2006년 11월부터 2009년 12월까지 갑상선 미세유두암을 고주파 절제술로 치료받은 환자 5명을 대상으로 하였다. 이 환자들은 모두 조직검사를 통해 갑상선 미세유두암으로 진단을 받았고, 병변은 갑상선 내에 국한되어 있었으며, 전이의 증거가 없었고, 수술이나 전신마취가 의학적으로 부적합하거나 수술을 거부한 환자들이었다. 고주파 절제술은 고주파 발생기와 냉각기를 사용하여 한 명의 영상의학과 의사가 시행하였다. 우리는 시술과 연관된 부작용, 소작된 종양의 변화, 재발 여부, 국소 또는 림프절 전이 등에 대해 초음파 영상 소견과 의무 기록을 토대로 분석하였다. 결과 평균 경과 관찰기간은 130.6개월(범위, 121~159개월) 이었다. 세 명의 환자는 한 번의 고주파 절제술을, 두 명의 환자는 두 번의 시술을 받았다. 다섯 명의 환자 모두 시술과 연관된 부작용은 보이지 않았다. 다섯 개 중 세 개의 종양은 시술 후 완전히 사라졌으며 두 개의 종양은 최소한의 흔적으로 남아 평균 16.8개월의 경과 관찰기간 동안 큰 변화가 없었다. 가장 최근의 경과관찰에서 다섯 명의 환자 모두 국소 전이나 림프절 전이는 보이지 않았고 갑상선 글로불린(thyroglobulin)의 수치도 정상 범위였다. 결론 고주파 절제술은 수술에 부적합하거나 수술을 거부하는 저위험 갑상선 미세유두암 환자들에 대해서 효과적이고 안전한 치료법이 될 수 있다.

성별, 연령별, 월소득차이에 따른 질병발생의 위험성 차이연구;암, 고혈압, 중풍, 당뇨병, 관절염, 심장병을 중심으로 (The Risk of Onset of the Illnesses Based on Gender, Age, and Monthly Income;Focusing on cancer, hypertension, stroke, diabetes, arthritis, cardiac disorders)

  • 이준오;김세진;이선동
    • 대한예방한의학회지
    • /
    • 제12권1호
    • /
    • pp.19-48
    • /
    • 2008
  • In order to verify the risk of onset of the illnesses based on gender, age, and monthly income 1,739 subjects from Hongcheon county, Gangwon province were selected. Questionnaire on demographic sociology, health condition, existence of illnesses(cancer, hypertension, stroke, diabetes, arthritis, cardiac disorders), and usage of public health services was surveyed from October 1, 2006 to October 20, 2006. Following conclusions were reached on the basis of the questionnaire : - For demographic sociological peculiarities, gender, age, occupation, and education level were evenly distributed. Most were under normal marriage(67.38%), health insurance(86.39%), 494(36.0%) individuals with less than monthly income of 1 million won, 494(36.0%) individuals with monthly income between 1 and 2 million won, 219(16.0%) with monthly income between 2 and 3 million won, and 164(12.0%) individuals with more than 3 million won, thus showing relatively low income. - For health status, 1,199(70.28%) individuals are non-smokers, 209(45.63%) individuals smoke $10{\sim}20$ cigarettes a day, 754(44.02%) individuals exercise less than twice a week are the major sector of the population. 1,518(88.10%) individuals have regular checkup more than once and 1,131(65.49%) stated their health condition less than average. - For comparison of existence of illnesses between genders, there was no statistical significance on cancer, stroke, and diabetes. But statistical significance was shown on hypertension(P value 0.025), arthritis(P value 0.000), and cardiac disorders(P value 0.016). Statistical significance was seen in the age comparison, and OR(confidence interval) drastically increased with increase in age. - There was no difference between the primary health clinic(P value 0.000), most visited clinic(P value 0.000), selection criteria(P value 0.000), and satisfaction on efficacy(P value 0.000). There was a tendency preferring hospital than public health center with increase in income. - For correlation between the existence of illnesses among different income levels, except for cancer(P value 0.172), statistical significance was seen in hypertension(P value 0.000), stroke(P value 0.003), diabetes (P value 0.001), arthritis(P value 0.000), and cardiac disorders(P value 0.000). The number of individuals suffering from illnesses and ratio all decreased for all illnesses with increase in income. - After adjusting confounding factors(gender, age, income, marriage, occupation, education) and male (1) as the standard, OR (confidence interval) of cancer, hypertension, stroke, diabetes, arthritis, cardiac disorders were 0.47(0.11${\sim}$2.05), 1.27(0.89${\sim}$1.81), 0.58(0.21${\sim}$1.59), 0.71(0.41${\sim}$1.23), 1.79(1.34${\sim}$2.39, P<0.01), and 1.46(0.72${\sim}$2.96), respectively. Risk of arthritis is significantly high in female and 20's (1) as the standard, OR(confidence interval) of cancer, hypertension, stroke, diabetes, arthritis, cardiac disorders were 1.01(0.96${\sim}$1.07), 1.06(1.04${\sim}$1.07, P<0.01), 1.05(1.01${\sim}$1.10, P<0.01), 1.06(1.03${\sim}$1.08, P<0.01), 1.05(1.03${\sim}$1.06, P<0.01), and 1.06(1.04${\sim}$1.09, P<0.01), respectively. Risk of onset for illnesses significantly increased with yearly aging except for cancer. - For comparison between monthly income after adjusting confounding factors(gender, age, income, marriage, occupation, education), with less than 1 million won (1) as the standard, OR(confidence interval) of cancer for 1 to 2 million won, 2 to 3 million won, and more than 3 million won were 0.23(0.03${\sim}$2.16), 2.53(0.41${\sim}$15.43), and 1.73(0.15${\sim}$19.50), respectively. OR(confidence interval) of hypertension were 1.12(0.76 ${\sim}$1.66), 0.68(0.34${\sim}$1.34), and 2.04(1.08${\sim}$3.86, P<0.01), respectively. OR(confidence interval) of stroke were 0.96(0.30${\sim}$3.08) for 1 to 2 million won, and 0.80(0.08${\sim}$8.46) for 2 to 3 million won. OR(confidence interval) of diabetes were 0.73(0.38${\sim}$1.38), 0.65(0.24${\sim}$1.71), and 0.69(0.24${\sim}$2.01), respectively. The values were 0.76(0.55${\sim}$1.03), 1.14(0.75${\sim}$1.73), and 0.90(0.56${\sim}$1.46), respectively for arthritis. OR(confidence interval) of cardiac disorders were 1.15(0.53${\sim}$2.48), 0.63(0.13${\sim}$3.12), and 1.20(0.28${\sim}$5.14), respectively. Risks of cancer, hypertension, stroke, diabetes, arthritis, and cardiac disorders were dependent of monthly income, and stroke and diabetes decreased with increase in income. Summarizing above data, arthritis was significantly higher in women and increase in age by each year brought significant increase in the chance of onset in hypertension, stroke, diabetes, arthritis, and cardiac disorders except for cancer. Stroke and diabetes decreased with increase in income. Above findings can be applied and reflected in public health policies at the national level, and it can also be applied at the personal level for individual health maintenance and prevention.

  • PDF

한국인에서 peroxisome proliferator-activated receptor alpha Leu162Val 유전자 다형성과 대사증후군간의 관련성 (Association between Genetic Polymorphism of Peroxisome Proliferator-Activated Receptor Alpha Leu162Val and Metabolioc Syndrome in Korean)

  • 신승철;송혜순;홍영습;곽종영;유병철;이용환
    • 생명과학회지
    • /
    • 제16권2호
    • /
    • pp.199-205
    • /
    • 2006
  • Peroxisome proliferator-activated receptors alpha (PPAR $\alpha$)는 지질대사와 관련하여 대사증후군 발생과 관련이 있을 수 있는 강력한 잠재 유전자로 고려되고 있으므로 한국인에 있어서 PPAR$\alpha$ L162V 유전자 다형성과 대사증후군과의 연관성을 확인하고자 고신대학교 복음병원에서 2004년 12윌에서 2005년 7월 사이에 건강진단을 받았던 수진자 542명(대사 증후군 : 262명, 정상인 : 280명)을 대상으로 신장, 체증, 체질량지수, 허리둘레와 수축기와 이완기 혈압, 공복 혈당, 총콜레스테롤, HDL 콜레스테롤, LDL 콜레스테롤과 중성지방 수치를 측정하였으며, 대사증후군의 정의는 혈압, 공복 혈당, HDL 콜레스테롤, 중성지방은 NCEP ATP III의 기준을 적용하였고, 허리둘레는 WHO 아시아-서태평양 기준을 적용하였다. PCR-ASO (polymerase chain reaction allele-specific oligonucleotide) 방법에 의해 대상자들의 PPAR$\alpha$ L162V 유전자 다형성을 확인하였다. 연구결과 PPAR$\alpha$ 484번 염기서열의 $C{\rightarrow}G$ 돌연변이가 나타난 사람은 조사대상자 542명 가운데 1명(0.2%) 이었다. 한국인에서는 PPAR$\alpha$ L162V 유전자 다형성이 거의 일어나지 않았으며, 이의 확인을 위하여 더욱 많은 사람을 대상으로 연구가 진행되어야 할 필요가 있을 것으로 생각된다.

연취급 근로자들의 혈중 ZPP 농도 선별기준에 따른 정확도의 변화 (The change of validity of blood zinc protoporphyrin test by different cut-off level in lead workers)

  • 김용배;안현철;황보영;리갑수;이성수;안규동;이병국
    • Journal of Preventive Medicine and Public Health
    • /
    • 제30권4호
    • /
    • pp.741-751
    • /
    • 1997
  • Measurement of blood lead (PbB) and blood zinc protoporphyrin (ZPP) are most common biological indices to identify the individual at risk for excess or the health sequences by lead exposure. Because PbB is known most important and reliable index of lead exposure, PbB is often regarded as a gold standard to detect lead exposure. But in Korea PbB is a secondary test item of detailed health check-up with positive finding of screening test in most occasion. Our lead standard requires all lead workers to take annual heath-check twice a year for investigation of their health effect due to lead exposure. Blood ZPP is one of most important index to detect high lead absorption in lead workers as a screening test. Measurement of blood ZPP is known ,well to correlate with PbB in steady state of exposure in most lead workers and is often used as a primary screening test to detect high lead absorption of lead workers with the advantage of simplicity, easiness, portability and low cost. The current cut-off criteria of blood ZPP for further detailed health check-up is $100{\mu}g/d\ell$ which is supposed to match the level of $40{\mu}g/d\ell$ of PbB according to our standard. Authors tried to investigate the validity of current criteria of cut-off level $(100{\mu}g/d\ell)$ of blood ZPP and possible another better cut-off level of it to detect the lead workers whose PbB level over $40{\mu}g/d\ell$. The subjects in our study were 212 male workers in three small scale storage battery industries. Blood ZPP, PbB and hemoglobin (Hb) were selected as the indices of lead exposure. The results were as follows. 1. The mean of blood ZPP, PbB and Hb in lead workers were $79.5{\pm}46.7{\mu}g/d\ell,\;38.7{\pm}15.1{\mu}g/d\ell,\;and\;14.8{\pm}1.2g/d\ell$, respectively. There were significant differences in blood ZPP, PbB and Hb by industry (P<0.01). 2. The percents of lead workers whose blood ZPP were above $100{\mu}g/d\ell$ in the group of work duration below 1, 1-4, 5-9 and above 10 years were 8.6%, 17.2%, 47.6%, and 50.0%, respectively. The percents of lead workers whose PbB were above $40{\mu}g/d\ell$ in those were 31.4%, 40.4%, 71.4%, and 86.4%, respectively. 3. The percents of lead workers whose PbB were below $40{\mu}g/d\ell$, $40-59{\mu}g/d\ell$ and above $60{\mu}g/d\ell$ were 54.7%, 34.9% and 10.4%, respectively. Those of lead workers whose blood ZPP were below $100{\mu}g/d\ell$, $100-149{\mu}g/d\ell$ and above $150{\mu}g/d\ell$ were 79.2%, 13.7% and 7.1%, respectively. 4. Simple linear regression of PbB on blood ZPP was statistically significant (P<0.01) and as PbB was $40{\mu}g/d\ell$, blood ZPP was $82.1{\mu}g/d\ell$. 5. While the highest sensitivity and specificity of blood ZPP test to detect lead workers with PbB eve. $40{\mu}g/d\ell$ were observed in the cut-off level of $50{\mu}g/d\ell$ and $100{\mu}g/d\ell$ of blood ZPP, respectively, the highest validity (sensitivity+specificity) of blood ZPP to detect lead workers with PbB over $40{\mu}g/d\ell$ was observed in the cut-off level of around $70{\mu}g/d\ell$ of blood ZPP. But even with optimal cut-off level of around $70{\mu}g/d\ell$ of blood ZPP, still 25.0% of false negative and 20.7% false positive lead workers were found. As the result of this study, it was suggested that reconsideration of current blood ZPP cut-off of our lead standard from $100{\mu}g/d\ell$ to somewhat lower level such as around $70{\mu}g/d\ell$ and the inclusion of PbB measurement as a primary screening test for lead workers was highly recommended for the effective prevention of lead workers.

  • PDF

$^{18}F-FDG$ PET/CT에서 우연히 발견된 국소 유방 병변의 임상적 의의 (Clinical Significance of Focal Breast Lesions Incidentally Identified by $^{18}F-FDG$ PET/CT)

  • 조영석;최준영;이수진;현승협;이지영;최용;최연성;이경한;김병태
    • Nuclear Medicine and Molecular Imaging
    • /
    • 제42권6호
    • /
    • pp.456-463
    • /
    • 2008
  • 목적 : $^{18}F-FDG$ PET/CT에서 우연히 발견되는 국소 유방 병변의 임상적인 중요성을 알아보기 위해 발병률과 악성 유무에 대해 살펴보았으며, PET/CT상 악성 병변을 시사하는 소견들을 알아보았다. 대상 및 방법: $^{18}F-FDG$ PET/CT를 시행 받은 3768명의 유방암의 병력이 없는 성인 여성을 대상으로 하여 후향적 평가를 실시하였다. 국소 유방 병변은 국소 $^{18}F-FDG$ 섭취증가 병변 또는 $^{18}F-FDG$ 섭취 양상과 관계없이 관찰되는 CT상의 결절성 병변으로 정의하였다. 이들 병변의 최대 SUV, 크기, CT상 결절성 변화 유무, 감쇠값 들을 분석하고, 이를 조직확인과 영상의학적 추가검사 그리고 임상적 추적관찰을 통해 얻은 최종 진단과 비교하였다. 결과: 53명에서 58개의 병면이 발견되어, 성인 여성의 $^{18}F-FDG$ PET/CT에서 국소 유방 병변의 발병률은 1.4%였다. 이중 추가적인 검사나 충분한 임상 추적 관찰이 시행되지 않아 분석에서 5명이 제외되었다. 나머지, 48명의 53개 병면에서 8명의 11개 병변(원발성 유방암 4, 전이성 유방암 7)이 악성으로 판명되어, 악성위험도는 20.8%였다. $^{18}F-FDG$ 섭취가 없는 CT상의 결절성 병변, CT상 결절이 보이지 않는 국소 $^{18}F-FDG$ 섭취증가 병변, 최대 감쇠값이 75 HU이상인 경우 또는 30 미만인 병변, 그리고 감쇠값의 표준 편차가 20 이상인 병변은 모두 양성으로 판명되었다. 최대 SUV만으로 악성 여부를 예측하는 경우 수신자판단특성 곡선의 곡선아래 면적은 0.580이었으나, 위에 언급한PET/CT소견을 보이는 유방병변들을 최대 SUV 관계없이 양성으로 판정하면, 곡선아래 면적이 0.768로 유의하게 증가하였다(p<0.05). 결론: 성인여성에서 $^{18}F-FDG$ PET/CT 시행시에 우연히 발견된 국소 유방 병변은 비교적 높은 악성 위험도를 갖고 있으므로 추가적인 진단적 검사가 요구된다. 특히, PET/CT의 CT 영상의 결절성병변 유무와 감쇠 양상을 고려하면, 악성 유방 병변에 대한 고위험 환자군을 선별하는 데 도움이 될 것으로 보인다.

신증후군 환아에서 스테로이드 유발 대사성 골질환에 대한 Alendronate의 치료 효과 (Therapeutic Efficacy of Alendronate for Glucocorticoid Induced Metabolic Bone Disease in Children with Nephrotic Syndrome)

  • 이지은;이현옥;백경훈;이숙향;진동규
    • Childhood Kidney Diseases
    • /
    • 제8권1호
    • /
    • pp.33-42
    • /
    • 2004
  • 목 적 : 소아 신증후군에서 스테로이드 장기투여에 따른 대사성 골질환은 흔한 합병증 중의 하나이다. 저자들은 성인에서의 스테로이드 유발성 골다공증 치료에 유효한 bisphosphonate(alendronate)를 투여하여 소아 신증후군에서 스테로이드 유발 대사성 골질환에 대한 치료효과에 대해 전향적으로 평가하고자 하였다. 방 법 : 신증후군 이환 기간이 2년된 5-8세의 환자 58명에게 DEXA로 골밀도를 측정하여 요추 골밀도가 Z-score -1 이하인 환아 30명(51.7%)을 대상으로 선정한 후 이들을 alendronate 주 1회 투여군, calcitriol 투여군, 약제 비투여군등의 세 군으로 분류하여 1년간 연구하였다. 치료 6개월, 1년에 요추 L1-L4 골밀도를 측정하였고 치료 전과 치료 1년 후 생화학적 검사를 측정하였다. 각 군간 평균 연령, 기저 요추 골밀도, 스테로이드 축적량, 골밀도% 변화율, 요추 골밀도 Z-score를 측정 분석하였다. 결 과 : 총 30명 환자에서 기본 요추 골밀도 측정시 환아의 나이는 $7.4{\pm}1.7$세였고 신증후군 이환기간은 $2.2{\pm}1.2$년이었다. Z-score로 진단된 골밀도 감소증은 23명(76.7%), 골다공증은 7명(23.3%)이었다. 각 생화학적 변수들은 치료 전후로 차이가 없었으며, 군 간에도 유의한 차이가 없었다(P>0.05). 빈번 재발형 신증후군과 스테로이드 의존형 신증후군은 22명(73.3%)으로 드문 재발형 신증후군 8명(26.6%)에 비해 대사성 골질환의 빈도가 높았다. 골밀도 변화율은 alendronate 군에서 치료 1년에 8.56%였고, calcitriol군은 5.79% 증가를 보였으며, 비투여군은 1.9%증가를 보였다. Z-socre 변화는 alendronate 군과 calcitriol 군에서만 호전되었고, 비투여군에서는 감소하였다. 골밀도 증가율은 각 군간 유의한 차이를 보였지만(P=0.0002), alendronate 군과 비투여군, calcitriol 군과 비투여군 간에 있었고(P<0.05), alendronate 군과 calcitriol 군간에는 유의한 차이가 없었다. Alendronate 투여시 약복용을 중단할 만큼의 심각한 부작용은 발현되지 않았다. 결 론 : 소아 신증후군 환자에서 고용량의 스테로이드를 투여해야 하는 경우 대사성 골질환의 발생 위험이 높기 때문에 정기적인 골밀도 측정이 필요하며, 그 평가 도구로는 요추 골밀도 Z-score가 유용함을 알 수 있었다. 또한 신증후군 환아의 스테로이드 유발 대사성 골질환에서 alendronate 주 1회 경구투여는 요추 골밀도를 증가시키는 효과적인 치료법이었다.

  • PDF